Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study Inflamm Bowel Dis. 2024 Mar 23:izae062. doi: 10.1093/ibd/izae062. Online ahead of print.
Sandra García-Mateo 1 2, Samuel Jesús Martínez-Domínguez 1 2, Carla Jerusalén Gargallo-Puyuelo 1 2, Beatriz Gallego 2, Erika Alfambra 2, María Escuin 1, Sergio García-Mateo 1, Julia López 1, Fernando Gomollón 1 2 3 4 |
Author information 1Department of Gastroenterology, Lozano Blesa University Clinical Hospital, 50009 Zaragoza, Spain. 2Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain. 3School of Medicine, University of Zaragoza, 50009 Zaragoza, Spain. 4CIBERehd, Madrid, Spain. Abstract Background: A healthy lifestyle, including good adherence to a Mediterranean diet (MD) and regular physical exercise, may be an important factor during the course of inflammatory bowel disease (IBD). Our aim is to determine whether adherence to MD, physical activity, and the combination of both can impact on IBD course. Methods: This prospective cohort study includes 693 IBD outpatients who were in remission with a median follow-up time of 27 months (interquartile range 22-29 months). Each patient completed a survey to assess their adherence to the MD and physical activity. Healthy lifestyle was considered to be a proper adherence to both MD and an active lifestyle. Relapse during follow-up, severity of relapses, need for systemic steroids, and therapy changes were recorded. Results: During the follow-up period, 188 patients (27.1%) experienced relapse, of which 56.1% were moderate or severe. Among patients with relapse, 85 (45%) required treatment with corticosteroids, and 15 (7.9%) were hospitalized. Patients with ulcerative colitis (CU) were more adherent to healthy lifestyle than patients with Crohn's disease (P = .011). Healthy lifestyle was associated with lower risk of moderate and severe relapses (adjusted Hazard ratio [aHR], 0.250; 95% confidence interval [CI], 0.093-0.670) and steroids use (aHR 0.292; 95% CI, 0.103-0.828) in IBD patients and with lower risk of moderate and severe relapses (aHR 0.270; 95% CI, 0.093-0.789) in UC patients. Conclusions: Healthy lifestyle has a favorable influence on promoting a milder disease course, and thus should be a crucial part of clinical management of patients with IBD. |
© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.